226 related articles for article (PubMed ID: 36003914)
1. A nomogram risk prediction model for no-reflow after primary percutaneous coronary intervention based on rapidly accessible patient data among patients with ST-segment elevation myocardial infarction and its relationship with prognosis.
Liu Y; Ye T; Chen K; Wu G; Xia Y; Wang X; Zong G
Front Cardiovasc Med; 2022; 9():966299. PubMed ID: 36003914
[TBL] [Abstract][Full Text] [Related]
2. Construction and evaluation of nomogram model for individualized prediction of risk of major adverse cardiovascular events during hospitalization after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction.
Fang C; Chen Z; Zhang J; Jin X; Yang M
Front Cardiovasc Med; 2022; 9():1050785. PubMed ID: 36620648
[TBL] [Abstract][Full Text] [Related]
3. A nomogram for predicting the risk of no-reflow after primary percutaneous coronary intervention in elderly patients with ST-segment elevation myocardial infarction.
Yang L; Cong H; Lu Y; Chen X; Liu Y
Ann Transl Med; 2021 Jan; 9(2):126. PubMed ID: 33569428
[TBL] [Abstract][Full Text] [Related]
4. Predictive value of triglyceride glucose index combined with neutrophil-to-lymphocyte ratio for major adverse cardiac events after PCI for acute ST-segment elevation myocardial infarction.
Wang L; Wang Y; Wang W; Wang Z
Sci Rep; 2024 Jun; 14(1):12634. PubMed ID: 38824158
[TBL] [Abstract][Full Text] [Related]
5. PTH Predicts the in-Hospital MACE After Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction.
Wu ZF; Su WT; Chen S; Xu BD; Zong GJ; Fang CM; Huang Z; Hu XJ; Wu GY; Ma XL
Ther Clin Risk Manag; 2023; 19():699-712. PubMed ID: 37641783
[TBL] [Abstract][Full Text] [Related]
6. MELD-XI score predict no-reflow phenomenon and short-term mortality in patient with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhang XT; Lin ZR; Zhang L; Zhao ZW; Chen LL
BMC Cardiovasc Disord; 2022 Mar; 22(1):113. PubMed ID: 35300593
[TBL] [Abstract][Full Text] [Related]
7. A Predictive Model for Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention in Elderly Patients with ST-Segment Elevation Myocardial Infarction.
Qiu H; Zhu Y; Shen G; Wang Z; Li W
Clin Interv Aging; 2023; 18():453-465. PubMed ID: 36987461
[TBL] [Abstract][Full Text] [Related]
8. In-hospital major adverse cardiovascular events after primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: a retrospective study under the China chest pain center (standard center) treatment system.
Huang L; Zhang J; Huang Q; Cui R; Chen J
BMC Cardiovasc Disord; 2023 Apr; 23(1):198. PubMed ID: 37069503
[TBL] [Abstract][Full Text] [Related]
9. Canada acute coronary syndrome risk score predicts no-/slow-reflow in ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Xie E; Li Q; Ye Z; Guo Z; Li Y; Shen N; Yu C; Gao Y; Zheng J
Heliyon; 2023 Nov; 9(11):e21276. PubMed ID: 37920501
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram model for predicting the occurrence of no-reflow phenomenon after percutaneous coronary intervention using the lncRNA
Hu CK; Cai RP; He L; He SR; Liao JY; Su Q
J Thorac Dis; 2022 Jun; 14(6):2158-2168. PubMed ID: 35813727
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of fibrinogen-to-albumin ratio to predict no-reflow and short-term prognosis in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Zhao Y; Yang J; Ji Y; Wang S; Wang T; Wang F; Tang J
Heart Vessels; 2019 Oct; 34(10):1600-1607. PubMed ID: 30993442
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of Nomogram for the Prediction of Malignant Ventricular Arrhythmia Including Circulating Inflammatory Cells in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Wang L; Yang L; Li T; Geng S
J Inflamm Res; 2023; 16():3185-3196. PubMed ID: 37529768
[TBL] [Abstract][Full Text] [Related]
14. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention.
Esenboğa K; Kurtul A; Yamantürk YY; Tan TS; Tutar DE
Acta Cardiol; 2022 Feb; 77(1):59-65. PubMed ID: 33612077
[TBL] [Abstract][Full Text] [Related]
15. The Systemic Immune-Inflammation Index Predicts Impaired Myocardial Perfusion and Short-Term Mortality in ST-Segment Elevation Myocardial Infarction Patients.
Vatan MB; Çakmak AC; Ağaç S; Eynel E; Erkan H
Angiology; 2023 Apr; 74(4):365-373. PubMed ID: 35670358
[TBL] [Abstract][Full Text] [Related]
16. The value of plasma D-dimer level on admission in predicting no-reflow after primary percutaneous coronary intervention and long-term prognosis in patients with acute ST segment elevation myocardial infarction.
Erkol A; Oduncu V; Turan B; Kılıçgedik A; Sırma D; Gözübüyük G; Karabay CY; Guler A; Dündar C; Tigen K; Pala S; Kırma C
J Thromb Thrombolysis; 2014 Oct; 38(3):339-47. PubMed ID: 24407374
[TBL] [Abstract][Full Text] [Related]
17. Predicting long-term prognosis after percutaneous coronary intervention in patients with new onset ST-elevation myocardial infarction: development and external validation of a nomogram model.
Ye Z; Xu Y; Tang L; Wu M; Wu B; Zhu T; Wang J
Cardiovasc Diabetol; 2023 Apr; 22(1):87. PubMed ID: 37055777
[TBL] [Abstract][Full Text] [Related]
18. Nomogram for Predicting In-Hospital Mortality in Patients with Acute ST-Elevation Myocardial Infarction Complicated by Cardiogenic Shock after Primary Percutaneous Coronary Intervention.
Wang Y; Liu L; Li X; Dang Y; Li Y; Wang J; Qi X
J Interv Cardiol; 2022; 2022():8994106. PubMed ID: 35356419
[TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of nomogram model for predicting major adverse cardiac events in patients with acute ST-segment elevation myocardial infarction based on glycosylated hemoglobin A1c to apolipoprotein A1 ratio: An observational study.
Zhang KP; Guo QC; Mu N; Liu CH
Medicine (Baltimore); 2024 Jun; 103(24):e38563. PubMed ID: 38875361
[TBL] [Abstract][Full Text] [Related]
20. Development and validation of a clinical risk score predicting the no-reflow phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Wang JW; Chen YD; Wang CH; Yang XC; Zhu XL; Zhou ZQ
Cardiology; 2013; 124(3):153-60. PubMed ID: 23485798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
